![Galapagos](/common/images/company/EU_GLPG.png)
Mechelen, Belgium; June 14, 2024, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will present encouraging new data from the ongoing Phase 1/2 ATALANTA-1 study of...
Adaptimmune and Galapagos to conduct clinical proof-of-concept trial to evaluate the safety and efficacy of uza-cel (next generation MAGE-A4 TCR T-cell therapy) produced on Galapagos’...
Galapagos creates new subscription right plans Mechelen, Belgium; 16 May 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its Board of...
Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S. BCA's national network of blood centers...
Advanced potentially best-in-class cell therapy and small molecule R&D pipeline comprising four clinical assets and >15 discovery programs in oncology and immunologyExecuted agreements with...
Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024 Mechelen, Belgium; 30 April 2024, 22:01 CET;...
Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024 Two oral presentations and one poster on encore...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.48 | 1.96238757155 | 24.46 | 25.2 | 23.9 | 68434 | 24.60401146 | DE |
4 | 0.94 | 3.91666666667 | 24 | 25.2 | 23.02 | 64843 | 24.12704838 | DE |
12 | -2.08 | -7.69800148038 | 27.02 | 28.42 | 23.02 | 80508 | 25.14257957 | DE |
26 | -10.26 | -29.1477272727 | 35.2 | 37.17 | 23.02 | 80194 | 28.47057135 | DE |
52 | -13.16 | -34.5406824147 | 38.1 | 40.26 | 23.02 | 84292 | 31.95609945 | DE |
156 | -25.56 | -50.6138613861 | 50.5 | 66.28 | 23.02 | 193048 | 45.01797324 | DE |
260 | -137.56 | -84.6523076923 | 162.5 | 252.9 | 23.02 | 314905 | 101.3423083 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.